 Bevacizumab | [ ] | 280 kB |
| Bevamerged.pdf | [ ] | 190 kB |
| bortezomib cont.pdf | [ ] | 276 kB |
| bortezomib first.pdf | [ ] | 233 kB |
| Dasatinib_cont. | [ ] | 112 kB |
| Dasatinib_first | [ ] | 102 kB |
| Deferasirox | [ ] | 98 kB |
| donepezil hcl_alzheimer's_continue | [ ] | 165 kB |
| Donepezil HCL_Alzheimer's_new | [ ] | 159 kB |
| Imatinib mesilate_CML_cont. | [ ] | 186 kB |
| Imatinib mesilate_CML_first | [ ] | 186 kB |
| Imatinib_ALL(Ph+)_cont | [ ] | 179 kB |
| Imatinib_ALL(Ph+)_first | [ ] | 179 kB |
| IVIG_autoimmune hemolytic anemia (AIHA) | [ ] | 201 kB |
| IVIG_Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | [ ] | 138 kB |
| IVIG_Guillain-Barre syndrome | [ ] | 189 kB |
| IVIG_hemophagocytic lymphohistiocytosis (HLH) | [ ] | 180 kB |
| IVIG_immune thrombocytopenia | [ ] | 129 kB |
| IVIG_myasthenic crisis | [ ] | 86 kB |
| IVIG_primary immunodeficiency diseases) | [ ] | 196 kB |
| Linezolid_MRSA infection | [ ] | 111 kB |
| Micafungin_invasive candidiasis (ampho B, fluconazole resistance) | [ ] | 131 kB |
| Nilotinib_CML_Cont.pdf | [ ] | 136 kB |
| Nilotinib_CML_first.pdf | [ ] | 129 kB |
| Rituximab Autoimmune encephalitis (cont.) | [ ] | 226 kB |
| Rituximab Autoimmune encephalitis (first) | [ ] | 315 kB |
| Rituximab CIDP (cont.) | [ ] | 187 kB |
| Rituximab CIDP (first) | [ ] | 312 kB |
| Rituximab MG_cont. | [ ] | 148 kB |
| Rituximab MG_first | [ ] | 155 kB |
| Rituximab NAM (cont.) | [ ] | 188 kB |
| Rituximab NAM (first) | [ ] | 303 kB |
| Rituximab neuromyelitis (NMOSD) (cont.) | [ ] | 188 kB |
| Rituximab neuromyelitis (NMOSD) (first) | [ ] | 214 kB |
| Rituximab_FCL_cont. | [ ] | 234 kB |
| Rituximab_FCL_first | [ ] | 240 kB |
| Rituximab_non-Hodgkin lymphoma type DLBCL_cont. | [ ] | 290 kB |
| Rituximab_non-Hodgkin lymphoma type DLBCL_first | [ ] | 292 kB |
| Voriconazole_invasive aspergillosis/ invasive fungal infection | [ ] | 153 kB |